• Home
  • Global News
  • Johnson & Johnson fined $8 billion for not telling consumers drug could grow breasts in men
Johnson & Johnson fined $8 billion for not telling consumers drug could grow breasts in men
Global  
indiatoday

A US jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one of its subsidiaries over a drug the companies made that is allegedly linked to the abnormal growth of female breast tissue in men.

 

Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.
 
The Philadelphia Court of Common Pleas jury’s verdict in favour of Nicholas Murray came in the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of the thousands of Risperdal cases pending in the state.
 
This jury, as have other juries in other litigations, once again imposed punitive damages on a corporation that valued profits over safety and profits over patients, Murray’s lawyers, Tom Kline and Jason Itkin, said in a joint statement. Johnson & Johnson and (subsidiary) Janssen chose billions over children.
 
J&J said the award was grossly disproportionate with the initial compensatory award in this case, and the company is confident it will be overturned. It added that the jury in the case had not been allowed to hear evidence of Risperdal’s benefits.
 
Professor Carl Tobias of the University of Richmond School of Law said he expects the punitive damages to be lowered on appeal, citing a US Supreme Court decision which found that few awards exceeding a single-digit ratio between punitive and compensatory damages, to a significant degree, will satisfy due process.
 
Tobias said the verdict was about sending a message.
 
A jury, if it’s outrageous enough conduct, will award a big number and let the lawyers and judges work it out, he said.
 
 

 

Tobias added that the verdict could be a sign that J&J will face more large damages awards in other Risperdal cases.
 
The kind of evidence in this trial may persuade another jury or judge to do something similar, he said.
 
Murray, like other male plaintiffs in the mass tort litigation over Risperdal, alleges that he developed breasts after being prescribed the medicine when he was a minor. The US Food and Drug Administration approved the drug in late 1993 for treating schizophrenia and episodes of bipolar mania in adults.
 
Plaintiffs claim that J&J failed to warn of the risk of gynecomastia, the development of enlarged breasts in males, associated with Risperdal, which they say the company marketed for unapproved uses with children.
 
In his lawsuit, Murray, now 26, alleged that he developed breasts after his doctors began prescribing him Risperdal off-label in 2003 after a psychologist diagnosed him with autism spectrum disorder. Doctors are allowed to prescribe medicines as they see fit, while companies are only allowed to promote their drugs for approved uses.
 
A jury in 2015 awarded Murray $1.75 million after finding J&J was negligent in failing to warn of the risk of gynecomastia. A state appeals court upheld the verdict in February 2018 but reduced it to $680,000.
 
Plaintiffs in the mass tort litigation had been barred from seeking punitive damages since 2014, when a state court judge ruled that the law of New Jersey, which prohibits punitive damages and is J&J’s home state, should be applied globally to the cases.
 
But a Pennsylvania Superior Court ruling in 2018 cleared the way for punitive damages awards, holding that the law of each plaintiff’s state should instead apply.
 

 
 


 
 


 
More in Global
Supermodel Bella Hadid is World's Most Beautiful Woman According to Sc...

Scientists determining the most beautiful woman on the planet according to the 'Golden Ratio of Beauty Phi Standards' have picked the Victoria's Secret ...

Recently posted . 8 views

US Sanctions Turkey, Trump Says Ready To "Swiftly Destroy" Its Economy

The actions came hours after regime troops returned for the first time in years to parts of northeastern Syria, invited by Kurdish fighters desperate for protecti...

Recently posted . 7 views

Facebook officially launches its cryptocurrency Libra despite defectio...

• Despite several high-profile defections and intense criticism from US regulators and politicians, Facebook officially launches ...

Recently posted . 13 views

Class 4 Student Refuses to Answer 'Offensive' Math Problem That Compar...

'I don’t think that math problem was very nice because that’s judging people’s weight,' little Rhythm wrote to her teacher.

Recently posted . 15 views

Travel on the cards? Here are five beautiful countries where Indians c...

With India’s rank slipping five positions from 81st to 86th as per the Henley Passport Index, the commotion among Indian travellers is obvious.

Recently posted . 53 views

Watch | The Hindu Explains: Why is Turkey bombing Syria?

A video explainer with The Hindu's International Affairs Editor Stanly Johny speaking about why Ankara is ready to risk NATO’s ire over a defence deal w...

Recently posted . 12 views

 
 
 

Prashnavali

Thought of the day

There is only one happiness in this life, to love and be loved.
Anonymous